|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,444.60 INR | +2.50% |
|
+0.21% | -4.41% |
| 09:52pm | Cipla Limited Receives U.S. Fda Approval for Generic Advair Diskus | CI |
| 07-24 | Jefferies Adjusts Cipla's Price Target to INR1,170 From INR1,120, Keeps at Underperform | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CIPLA LIMITED | Generic Pharmaceuticals | +2.50% | +0.21% | -4.41% | -5.74% | +58.21% | 11.87B |  |  | |
- Stock Market
- Stocks
- CIPLA Stock
- Charts Cipla Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
